BHLHE41/DEC2 is expected to be an early inactivated molecule in NSCLC, possibly because BHLHE41/DEC2 is vulnerable to protein stability and epigenetic regulation of mRNA expression. This evidence concerns the gene BHLHE41 and non-small cell lung carcinoma.